Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pieper

Showing results (121-130 of 247) with videos related to

Pageof 25
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 5, 2007
Complementary effects of thienopyridine pretreatment and platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention; results from the ESPRIT trialJean-Pierre Dery, Mark E Campbell, Jasmine Mathias, et al.
Circulation|November 1, 1994
Aortic valve replacement in adults after balloon aortic valvuloplastyE B Lieberman, J S Wilson, J K Harrison, et al.
European Heart Journal|October 13, 2005
Predictors of mortality and morbidity in patients with chronic heart failureStuart J Pocock, Duolao Wang, Marc A Pfeffer, et al.
European Journal of Heart Failure|January 30, 2009
Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)Nathaniel M Hawkins, Zhen Huang, Karen S Pieper, et al.
American Heart Journal|May 26, 2009
Validity of a risk-prediction tool for hospital mortality: the Global Registry of Acute Coronary EventsKaren S Pieper, Joel M Gore, Gordon FitzGerald, et al.
The American Journal of Cardiology|April 1, 1993
Minimizing the risk of inappropriately administering thrombolytic therapy (Thrombolysis and Angioplasty in Myocardial Infarction [TAMI] study group)G D Chapman, E M Ohman, E J Topol, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 1, 2010
Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trialMarc Cohen, Glenn N Levine, Karen S Pieper, et al.
Clinical Cardiology|March 12, 2014
Comparison of clinical trial outcome patterns in patients following acute coronary syndromes and in patients with chronic stable atherosclerosisKenneth W Mahaffey, Daniel M Wojdyla, Karen S Pieper, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|June 3, 2005
A semiological classification of status epilepticusH O Lüders, S Rona, F Rosenow, et al.
Critical Care Medicine|June 14, 2013
The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarctionSean van Diepen, John P Vavalle, L Kristin Newby, et al.
Pageof 25

Showing results (121-130 of 247) with videos related to

Sort By:
Pageof 25
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 5, 2007
Complementary effects of thienopyridine pretreatment and platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention; results from the ESPRIT trialJean-Pierre Dery, Mark E Campbell, Jasmine Mathias, et al.
Circulation|November 1, 1994
Aortic valve replacement in adults after balloon aortic valvuloplastyE B Lieberman, J S Wilson, J K Harrison, et al.
European Heart Journal|October 13, 2005
Predictors of mortality and morbidity in patients with chronic heart failureStuart J Pocock, Duolao Wang, Marc A Pfeffer, et al.
European Journal of Heart Failure|January 30, 2009
Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)Nathaniel M Hawkins, Zhen Huang, Karen S Pieper, et al.
American Heart Journal|May 26, 2009
Validity of a risk-prediction tool for hospital mortality: the Global Registry of Acute Coronary EventsKaren S Pieper, Joel M Gore, Gordon FitzGerald, et al.
The American Journal of Cardiology|April 1, 1993
Minimizing the risk of inappropriately administering thrombolytic therapy (Thrombolysis and Angioplasty in Myocardial Infarction [TAMI] study group)G D Chapman, E M Ohman, E J Topol, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 1, 2010
Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trialMarc Cohen, Glenn N Levine, Karen S Pieper, et al.
Clinical Cardiology|March 12, 2014
Comparison of clinical trial outcome patterns in patients following acute coronary syndromes and in patients with chronic stable atherosclerosisKenneth W Mahaffey, Daniel M Wojdyla, Karen S Pieper, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|June 3, 2005
A semiological classification of status epilepticusH O Lüders, S Rona, F Rosenow, et al.
Critical Care Medicine|June 14, 2013
The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarctionSean van Diepen, John P Vavalle, L Kristin Newby, et al.
Pageof 25